ReviewHeliyon2024

Immune checkpoint blockade and CAR T-cell therapy in T-cell/histiocyte-rich large B-cell lymphoma: Challenges and opportunities.

Taha Koray Sahin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.